A carregar...

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

The tyrosine kinase inhibitors (TKI) against epidermal growth factor receptor (EGFR) are widely used in patients with non-small cell lung cancer (NSCLC). However, EGFR T790M mutation leads to resistance to most clinically available EGFR TKIs. Third-generation EGFR TKIs against the T790M mutation hav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Wang, Shuhang, Cang, Shundong, Liu, Delong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4830020/
https://ncbi.nlm.nih.gov/pubmed/27071706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0268-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!